Healthline: Daily News Newsletter
New COVID-19 boosters could be authorized by the FDA before full data from human trials are in because of past data on similar vaccines. With the COVID-19 vaccines, there is already a long track record of safety to support the new boosters.
Healthline Daily News Healthline Daily News
Pfizer Says Bivalent COVID-19 Booster Significantly Increases Antibodies to Fight Omicron
Pfizer Says Bivalent COVID-19 Booster Significantly Increases Antibodies to Fight Omicron
New COVID-19 boosters could be authorized by the FDA before full data from human trials are in because of past data on similar vaccines. With the COVID-19 vaccines, there is already a long track record of safety to support the new boosters.
Read on
Daylight Saving Time Ends This Sunday, How it Can Impact Your Sleep
Daylight Saving Time Ends This Sunday, How it Can Impact Your Sleep
READ ON Read on
Dementia Risk Linked to How Long Blood Pressure Stays In 'Target Range'
Dementia Risk Linked to How Long Blood Pressure Stays In 'Target Range'
READ ON Read on
How Do I Cope with 'Chemo-Brain'?
SPONSORED
How Do I Cope with 'Chemo-Brain'?
READ MORE Read on
Dialysis May Not Be Best Treatment for Some with Advanced Kidney Disease: Here's Why
Dialysis May Not Be Best Treatment for Some with Advanced Kidney Disease: Here's Why
READ ON Read on
Single Dose of Synthetic ‘Magic Mushroom’ Psilocybin Eases Severe Depression
Single Dose of Synthetic ‘Magic Mushroom’ Psilocybin Eases Severe Depression
READ ON Read on
More Top Reads
Start a custom weight loss program
Advertisement
Start a custom weight loss program
Noom helps you adopt healthy habits so you can lose weight and keep it off.
GET STARTED
View in browser
Did a friend send you this email? Subscribe here.
To see all newsletters, click here.
Privacy Policy|Unsubscribe
© 2022 Healthline Media
660 3rd Street, San Francisco, CA 94107